209 related articles for article (PubMed ID: 22198715)
41. NCR1-deficiency diminishes the generation of protective murine cytomegalovirus antibodies by limiting follicular helper T-cell maturation.
Miletic A; Lenartic M; Popovic B; Brizic I; Trsan T; Miklic K; Mandelboim O; Krmpotic A; Jonjic S
Eur J Immunol; 2017 Sep; 47(9):1443-1456. PubMed ID: 28643847
[TBL] [Abstract][Full Text] [Related]
42. Expression, Function, and Molecular Properties of the Killer Receptor Ncr1-Noé.
Glasner A; Simic H; Miklić K; Roth Z; Berhani O; Khalaila I; Jonjic S; Mandelboim O
J Immunol; 2015 Oct; 195(8):3959-69. PubMed ID: 26371250
[TBL] [Abstract][Full Text] [Related]
43. Natural killer cell recognition and killing of activated hepatic stellate cells.
Clària J
Gut; 2012 Jun; 61(6):792-3. PubMed ID: 22466617
[No Abstract] [Full Text] [Related]
44. NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.
Romero AI; Thorén FB; Brune M; Hellstrand K
Br J Haematol; 2006 Jan; 132(1):91-8. PubMed ID: 16371024
[TBL] [Abstract][Full Text] [Related]
45. Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1).
Durrenberger PF; Ettorre A; Kamel F; Webb LV; Sim M; Nicholas RS; Malik O; Reynolds R; Boyton RJ; Altmann DM
J Neuroinflammation; 2012 Jan; 9():1. PubMed ID: 22212381
[TBL] [Abstract][Full Text] [Related]
46. Dependence of innate lymphoid cell 1 development on NKp46.
Wang Y; Dong W; Zhang Y; Caligiuri MA; Yu J
PLoS Biol; 2018 Apr; 16(4):e2004867. PubMed ID: 29702643
[TBL] [Abstract][Full Text] [Related]
47. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.
Wijaya RS; Read SA; Schibeci S; Eslam M; Azardaryany MK; El-Khobar K; van der Poorten D; Lin R; Yuen L; Lam V; George J; Douglas MW; Ahlenstiel G
J Hepatol; 2019 Aug; 71(2):252-264. PubMed ID: 30905683
[TBL] [Abstract][Full Text] [Related]
48. Amelioration of hepatic fibrosis by NK cell activation.
Muhanna N; Abu Tair L; Doron S; Amer J; Azzeh M; Mahamid M; Friedman S; Safadi R
Gut; 2011 Jan; 60(1):90-8. PubMed ID: 20660699
[TBL] [Abstract][Full Text] [Related]
49. Natural killer cells control metastasis via structural editing of primary tumors in mice.
Isaacson B; Mandelboim O
Cancer Immunol Immunother; 2019 Oct; 68(10):1721-1724. PubMed ID: 31606778
[TBL] [Abstract][Full Text] [Related]
50. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
[TBL] [Abstract][Full Text] [Related]
51. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.
Jeong WI; Park O; Radaeva S; Gao B
Hepatology; 2006 Dec; 44(6):1441-51. PubMed ID: 17133483
[TBL] [Abstract][Full Text] [Related]
52. NKp46
Pionnier N; Furlong-Silva J; Colombo SAP; Marriott AE; Chunda VC; Ndzeshang BL; Sjoberg H; Archer J; Steven A; Wanji S; Taylor MJ; Turner JD
Front Immunol; 2022; 13():969340. PubMed ID: 36238293
[TBL] [Abstract][Full Text] [Related]
53. NKp46 Calibrates Tumoricidal Potential of Type 1 Innate Lymphocytes by Regulating TRAIL Expression.
Turchinovich G; Ganter S; Bärenwaldt A; Finke D
J Immunol; 2018 Jun; 200(11):3762-3768. PubMed ID: 29661825
[TBL] [Abstract][Full Text] [Related]
54. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells.
Mandelboim O; Lieberman N; Lev M; Paul L; Arnon TI; Bushkin Y; Davis DM; Strominger JL; Yewdell JW; Porgador A
Nature; 2001 Feb; 409(6823):1055-60. PubMed ID: 11234016
[TBL] [Abstract][Full Text] [Related]
55. The expression of the beta cell-derived autoimmune ligand for the killer receptor nkp46 is attenuated in type 2 diabetes.
Gur C; Enk J; Weitman E; Bachar E; Suissa Y; Cohen G; Schyr RB; Sabanay H; Horwitz E; Glaser B; Dor Y; Pribluda A; Hanna JH; Leibowitz G; Mandelboim O
PLoS One; 2013; 8(8):e74033. PubMed ID: 24009765
[TBL] [Abstract][Full Text] [Related]
56. Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell.
Ai WL; Dong LY; Wang J; Li ZW; Wang X; Gao J; Wu Y; An W
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3780-3791. PubMed ID: 30251695
[TBL] [Abstract][Full Text] [Related]
57. Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis.
Gao B; Radaeva S; Jeong WI
Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):173-80. PubMed ID: 19072444
[TBL] [Abstract][Full Text] [Related]
58. NK cell development in bone marrow and liver: site matters.
Gotthardt D; Prchal-Murphy M; Seillet C; Glasner A; Mandelboim O; Carotta S; Sexl V; Putz EM
Genes Immun; 2014 Dec; 15(8):584-7. PubMed ID: 25319498
[TBL] [Abstract][Full Text] [Related]
59. Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research.
Berhani O; Glasner A; Kahlon S; Duev-Cohen A; Yamin R; Horwitz E; Enk J; Moshel O; Varvak A; Porgador A; Jonjic S; Mandelboim O
Eur J Immunol; 2019 Feb; 49(2):228-241. PubMed ID: 30536875
[TBL] [Abstract][Full Text] [Related]
60. Role of NKp46
Haspeslagh E; van Helden MJ; Deswarte K; De Prijck S; van Moorleghem J; Boon L; Hammad H; Vivier E; Lambrecht BN
EMBO Mol Med; 2018 Apr; 10(4):. PubMed ID: 29444897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
